| | |
| | |
Stat |
Members: 3643 Articles: 2'487'895 Articles rated: 2609
28 March 2024 |
|
| | | |
|
Article overview
| |
|
NO-independent regulatory site on soluble guanylate cyclase | J P Stasch
; E M Becker
; C Alonso-Alija
; H Apeler
; K Dembowsky
; A Feurer
; R Gerzer
; T Minuth
; E Perzborn
; U Pleiss
; H Schröder
; W Schroeder
; E Stahl
; W Steinke
; A Straub
; M Schramm
; | Date: |
8 Mar 2001 | Journal: | Nature, 410 (6825), 212-5 | Abstract: | Nitric oxide (NO) is a widespread, potent, biological mediator that has many physiological and pathophysiological roles. Research in the field of NO appears to have followed a straightforward path, and the findings have been progressive: NO and cyclic GMP are involved in vasodilatation; glycerol trinitrate relaxes vascular smooth muscles by bioconversion to NO; mammalian cells synthesize NO; and last, NO mediates vasodilatation by stimulating the soluble guanylate cyclase (sGC), a heterodimeric (alpha/beta) haem protein that converts GTP to cGMP2-4. Here we report the discovery of a regulatory site on sGC. Using photoaffinity labelling, we have identified the cysteine 238 and cysteine 243 region in the alpha1-subunit of sGC as the target for a new type of sGC stimulator. Moreover, we present a pyrazolopyridine, BAY 41-2272, that potently stimulates sGC through this site by a mechanism that is independent of NO. This results in antiplatelet activity, a strong decrease in blood pressure and an increase in survival in a low-NO rat model of hypertension, and as such may offer an approach for treating cardiovascular diseases. | Source: | PubMed, pmid11242081 doi: 10.1038/35065611 | Services: | Forum | Review | Favorites |
|
|
No review found.
Did you like this article?
Note: answers to reviews or questions about the article must be posted in the forum section.
Authors are not allowed to review their own article. They can use the forum section.
browser claudebot
|
| |
|
|
|
| News, job offers and information for researchers and scientists:
| |